In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...

HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.

Adams, who served as surgeon general during the first Trump administration, said Kennedy's assertions about the efficacy of ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

The government has canceled nearly $500 million in research grants into the revolutionary technology, which experts believe ...

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

The U.S. Department of Health and Human Services announced on Tuesday that it will cancel $500 million worth of projects ...

HIV vaccines have been in development for decades, but a long-lasting one has yet to be successful. The mRNA technology offers new opportunities because mRNA produces a more potent antibody response.

Moderna's mRNA tech could change the game in the decades-long effort to develop an HIV vaccine. The company said it expects to begin two vaccine trials in humans by the end of 2021.